NOVONESIS (NOVOZYMES) B (NZM2.DE) Stock Overview
Europe - FRA:NZM2 - DK0060336014 - Common Stock
NZM2.DE Key Statistics, Chart & Performance
The current stock price of NZM2.DE is 51.16 EUR.
NZM2.DE Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| GIN.DE | GIVAUDAN-REG | 26.46 | 32.66B | ||
| 1SIKA.MI | SIKA AG-REG | 24.05 | 31.45B | ||
| SIKA.DE | SIKA AG-REG | 23.34 | 30.53B | ||
| 6D81.DE | DUPONT DE NEMOURS INC | 17.59 | 27.98B | ||
| BRG.OL | BORREGAARD ASA | 22.21 | 19.72B | ||
| DSFIR.AS | DSM-FIRMENICH AG | 78.66 | 19.64B | ||
| ELK.OL | ELKEM ASA | N/A | 16.01B | ||
| SY1.DE | SYMRISE AG | 20.72 | 10.51B | ||
| 1COV.DE | COVESTRO AG | N/A | 10.48B | ||
| AKZA.AS | AKZO NOBEL N.V. | 16.2 | 10.45B | ||
| AMC.DE | ALBEMARLE CORP | N/A | 8.15B | ||
| EVK.DE | EVONIK INDUSTRIES AG | 9.2 | 7.16B |
Related stock screener links
About NZM2.DE
Company Profile
Novonesis (Novozymes A/S) engages in the era of biosolutions. The firm operates in four geographical regions: Europe, Middle East & Africa (including Denmark), North America, Asia Pacific and Latin America. The company develops and distributes solutions within the market areas agriculture, bioenergy, food & beverages, household care, leather, pharmaceuticals, forest products, textile and wastewater solutions. Novozymes operates through a range of partnerships with companies, such as Bayer and Syngenta in Agriculture and DSM and Adisseo in Animal Health & Nutrition..
Company Info
NOVONESIS (NOVOZYMES) B
Krogshoejvej 36
Bagsvaerd DK
Employees: 10582
NOVONESIS (NOVOZYMES) B / NZM2.DE FAQ
What is the stock price of NOVONESIS (NOVOZYMES) B today?
The current stock price of NZM2.DE is 51.16 EUR. The price decreased by -3.73% in the last trading session.
What is the ticker symbol for NOVONESIS (NOVOZYMES) B stock?
The exchange symbol of NOVONESIS (NOVOZYMES) B is NZM2 and it is listed on the Deutsche Boerse Ag exchange.
On which exchange is NZM2.DE stock listed?
NZM2.DE stock is listed on the Deutsche Boerse Ag exchange.
What is NOVONESIS (NOVOZYMES) B worth?
NOVONESIS (NOVOZYMES) B (NZM2.DE) has a market capitalization of 21.21B EUR. This makes NZM2.DE a Large Cap stock.
How many employees does NOVONESIS (NOVOZYMES) B have?
NOVONESIS (NOVOZYMES) B (NZM2.DE) currently has 10582 employees.
Is NOVONESIS (NOVOZYMES) B (NZM2.DE) expected to grow?
The Revenue of NOVONESIS (NOVOZYMES) B (NZM2.DE) is expected to grow by 5.81% in the next year. Check the estimates tab for more information on the NZM2.DE EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy NOVONESIS (NOVOZYMES) B (NZM2.DE) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of NZM2.DE, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of NZM2.DE, evaluating the profitability, health, valuation and growth aspects
- NOVONESIS (NOVOZYMES) B (NZM2.DE) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- NOVONESIS (NOVOZYMES) B (NZM2.DE) Sales and EPS estimates to see what analysts future expectations are.
- NOVONESIS (NOVOZYMES) B (NZM2.DE) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- NOVONESIS (NOVOZYMES) B (NZM2.DE) Insider and Institutional Ownership to learn about the owners and their transactions.
- NOVONESIS (NOVOZYMES) B (NZM2.DE) Stock Chart to make your own analysis
- NOVONESIS (NOVOZYMES) B (NZM2.DE) Latest news and press-releases to stay up to date.
Does NOVONESIS (NOVOZYMES) B (NZM2.DE) stock pay dividends?
NOVONESIS (NOVOZYMES) B (NZM2.DE) has a dividend yield of 1.63%. The yearly dividend amount is currently 0.67. Check the full fundamental report for a detailed analysis of NZM2.DE dividend history, reliability and sustainability.
When does NOVONESIS (NOVOZYMES) B (NZM2.DE) report earnings?
NOVONESIS (NOVOZYMES) B (NZM2.DE) will report earnings on 2025-11-06.
What is the Price/Earnings (PE) ratio of NOVONESIS (NOVOZYMES) B (NZM2.DE)?
The PE ratio for NOVONESIS (NOVOZYMES) B (NZM2.DE) is 76.36. This is based on the reported non-GAAP earnings per share of 0.67 and the current share price of 51.16 EUR. Check the full fundamental report for a full analysis of the valuation metrics for NZM2.DE.
NZM2.DE Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to NZM2.DE.
NZM2.DE Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to NZM2.DE. Both the profitability and the financial health of NZM2.DE get a neutral evaluation. Nothing too spectacular is happening here.
NZM2.DE Financial Highlights
Over the last trailing twelve months NZM2.DE reported a non-GAAP Earnings per Share(EPS) of 0.67. The EPS decreased by -54.37% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 7.98% | ||
| ROA | 1.86% | ||
| ROE | 2.85% | ||
| Debt/Equity | 0.28 |
NZM2.DE Forecast & Estimates
For the next year, analysts expect an EPS growth of 44.26% and a revenue growth 5.81% for NZM2.DE